Veterinary Iron Dextran
Pharmacosmos veterinary Iron Dextran is the worldwide most commonly used medicine for prevention of piglet anemia. Pharmacosmos branded veterinary Iron Dextran compound Uniferon® is currently marketed in selected European countries as well as countries outside Europe.
The active pharmaceutical ingredient (API) in veterinary Iron Dextran solution for injection is an Iron(III) Dextran complex. Well-characterized and highly purified Dextran fractions are used in manufacturing of veterinary Iron Dextran at Pharmacosmos providing unique product characteristics and an advantageous safety profile.
The effect of veterinary Iron Dextran in treatment of piglet anemia is well documented and injection of Iron Dextran in piglets leads to a significant increase in haemoglobin values. Typically 1 mL veterinary Iron Dextran 20% (Uniferon® 20%) is injected on the 3rd day of life.
An efficient and correct iron treatment for piglets with veterinary Iron Dextran from Pharmacosmos ensures good health, optimum growth, and increased resistance against diseases.
Veterinary Medicine Manufacturing
Pharmacosmos veterinary Iron Dextran is approved in North, Central, and South America, Europe, South East Asia, Australia and Japan. Furthermore, Pharmacosmos 20% veterinary Iron Dextran is the only 200 mg iron(III)/mL preparation approved in the US.
The production of veterinary Iron Dextran at Pharmacosmos is performed in compliance with Good Manufacturing Practice for pharmaceutical ingredient according to The Rules governing Medicinal Products in the European Union Volume 4, Part II (former Annex 18 (ICH Q7A)), and our process and fractionation technology assures product consistency, purity, and efficacy. The facility is approved by the Danish Medicines Agency (Lægemiddelstyrelsen) and accepted by the US FDA. For further information regarding Dextran and Iron Dextran manufacturing approvals please visit Pharmacosmos Certificates & Approvals.